Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies

J Diabetes. 2020 Nov;12(11):860-861. doi: 10.1111/1753-0407.13080. Epub 2020 Jul 17.

Affiliations

¹ Endocrinology and Diabetes Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
² Gynecology and Obstetric Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
³ FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
⁴ Neonatology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.

PMID: 32594625
DOI: 10.1111/1753-0407.13080

No abstract available

Keywords: continuous subcutaneous insulin infusion; large for gestational age; multiple daily injections; pregnancy; type 1 diabetes.

Publication types

Letter
Observational Study

MeSH terms

Adult
Aged
Cohort Studies
Diabetes Mellitus, Type 1 / drug therapy*
Female
Humans
Hypoglycemic Agents / administration & dosage
Hypoglycemic Agents / therapeutic use
Infant, Newborn
Infusions, Subcutaneous
Injections
Insulin / administration & dosage
Insulin / therapeutic use*
Insulin Infusion Systems
Pregnancy
Treatment Outcome

Substances

Hypoglycemic Agents
Insulin